描述

Metabolomics is an analytical profiling technique for measuring and comparing large numbers of metabolites present in biological samples. Combining high-throughput analytical chemistry and multivariate data analysis, metabolomics offers a window on metabolic mechanisms. The global metabolomics market is poised to grow by US$ 12.1 亿期间 2022-2028, 复合年增长率为 11.8% 在预测期内, 据数据和分析公司 StrategyHelix 称.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for metabolomics. The global metabolomics market is segmented on the basis of product, indication, 应用, 和地区. 副产品, the global metabolomics market has been segmented into assays, bioinformatics, detection techniques, separation techniques. The separation techniques segment was the largest contributor to the global metabolomics market in 2021. Based upon indication, the global metabolomics market is categorized into cancer, cardiovascular disorders, inborn errors of metabolism, neurological disorders, 其他的. 据研究, the cancer segment had the largest share in the global metabolomics market. 根据应用, the global metabolomics market has been segmented into biomarker discovery, drug discovery, functional genomics, nutrigenomics, toxicology testing, 其他的. The biomarker discovery segment held the largest revenue share in 2021. 地理上, the global metabolomics market is segmented into Asia Pacific, 欧洲, 北美, 事物 (中东和非洲), 拉美. 全球范围, North America made up the largest share of the metabolomics market.

The separation techniques market is further segmented into capillary electrophoresis, gas chromatography, and liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography). The liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography) segment is estimated to account for the largest share of the global metabolomics market. 此外, the detection techniques market has been categorized into mass spectrometry, multivariate analysis, and spectroscopy (NMR and FTIR). The mass spectrometry segment held the largest share of the global metabolomics market in 2021 预计在预测期内将持有其份额.

The global metabolomics market is highly competitive. The report also includes the profiles of leading companies such as Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, LECO Corporation, Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the metabolomics market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

产品: assays, bioinformatics, detection techniques, separation techniques
Indication: cancer, cardiovascular disorders, inborn errors of metabolism, neurological disorders, 其他的
应用: biomarker discovery, drug discovery, functional genomics, nutrigenomics, toxicology testing, 其他的
地区: 亚太地区, 欧洲, 北美, 事物 (中东和非洲), 拉美
考虑的年数: 本报告涵盖期间 2018 到 2028

利益相关者的主要好处

– Get a comprehensive picture of the global metabolomics market
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. Metabolomics market overview
部分 3. 按产品划分的市场细分
– Assays
– Bioinformatics
– Detection techniques
– Separation techniques
部分 4. Market breakdown by indication
– Cancer
– Cardiovascular disorders
– Inborn errors of metabolism
– Neurological disorders
– 其他的
部分 5. 按应用划分的市场细分
– Biomarker discovery
– Drug discovery
– Functional genomics
– Nutrigenomics
– Toxicology testing
– 其他的
部分 6. 按地区划分的市场细分
– 亚太地区
– 欧洲
– 北美
– 事物 (中东和非洲)
– 拉美
部分 7. 重点企业
– Agilent Technologies Inc.
– Bio-Rad Laboratories Inc.
– Bruker Corporation
– Danaher Corporation
– LECO Corporation
– Metabolon Inc.
– Shimadzu Corporation
– Thermo Fisher Scientific Inc.
– Waters Corporation
关于StrategyHelix
免责声明